Tevogen Inc.
TVGN· Nasdaq
TVGNTevogen Inc.
Filed May 15, 2026 · 10-Q · 45 days after period end · 0001493152-26-023920
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$5.45M | -$10.37M | $11.26M | -$30.76M |
| EPS Diluted | -$1.61 | -$3.25 | -$0.26 | -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end
